v3.26.1
Summary of Common Stock Reserved for Future Issuance (Details)
Mar. 31, 2026
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Common stock reserved upon exercise of stock options outstanding 3,324
Common stock reserved upon exercise of common stock warrants 10,595,016
Common stock reserved for the exercise of purchase rights 741,490,642
Common stock reserved for the conversion of convertible notes 438,939,639
Common stock reserved for the conversion of series E-1 preferred stock 46,689,005
Common stock reserved for the conversion of series E-1 preferred stock 101,343,389
Total common stock reserved for future issuance 1,394,129,570 [1]
Employee Stock Purchase Plan 2019 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Common Stock available for future issuance under the 2025 Plan 509
Amended Inducement Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Common Stock available for future issuance under the 2025 Plan 609
2025 Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Common Stock available for future issuance under the 2025 Plan 55,067,437
[1] The potentially dilutive securities in Note 2 – Summary of Significant Accounting Policies includes all potentially dilutive securities that are not included in the diluted net income (loss) per share as per U.S. GAAP, whereas the total Common Stock reserved for future issuance in the table above includes the shares that must legally be reserved based on the applicable instruments’ agreements.